A follow-up study of mortality among women in the North American synthetic rubber industry

Journal of Occupational and Environmental Medicine

Volumn 51, Issue 11, 2009, Pages 1314-1325

  Sathiakumar, Nalini ^a   Delzell, Elizabeth ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BUTADIENE; STYRENE;

ADULT; AGED; ARTICLE; BLADDER CANCER; BREAST CANCER; CANCER MORTALITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HODGKIN DISEASE; HUMAN; LEUKEMIA; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; MORTALITY; MULTIPLE MYELOMA; NORTH AMERICA; OCCUPATIONAL EXPOSURE; OVARY CANCER; RUBBER INDUSTRY; STANDARDIZED MORTALITY RATIO;

EID: 74549115781     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e3181bd8972     Document Type: Article

References (57)

1. Cheng H, Sathiakumar N, Graff J, Matthews R, Delzell E. 1,3-Butadiene and leukemia among synthetic rubber industry workers: exposure-response relationships. Chem Biol Interact. 2007; 166:15-24. (Pubitemid 46413225)
2. Delzell E, Macaluso M, Sathiakumar N, Matthews R. Leukemia and exposure to 1,3-butadiene, styrene and dimethyldithiocarbamate among workers in the synthetic rubber industry. Chem Biol Interact. 2001;135-136:515-534.
3. Delzell E, Sathiakumar N, Graff J, Macaluso M, Maldonado G, Matthews R. An updated study of mortality among North American synthetic rubber industry workers. Res Rep Health Eff Inst. 2006;132:1-84.
4. Delzell E, Sathiakumar N, Hovinga M, et al. A follow-up study of synthetic rubber workers. Toxicology. 1996;113:182-189.
5. Graff J, Sathiakumar N, Macaluso M, Maldonado G, Matthews R, Delzell E. Chemical exposures in the synthetic rubber industry and lymphohematopoietic cancer mortality. J Occup Environ Med. 2005;47:916-932. (Pubitemid 41306704)
6. Macaluso M, Larson R, Delzell E, et al. Leukemia and cumulative exposure to butadiene, styrene and benzene among workers in the synthetic rubber industry. Toxicology. 1996;113:190-202.
7. Macaluso M, Larson R, Lynch J, Lipton S, Delzell E. Historical estimation of exposure to 1,3-butadiene, styrene, and dimethyldithiocarbamate among synthetic rubber workers. J Occup Environ Hyg. 2004;1:371-390.
8. Sathiakumar N, Graff J, Macaluso M, Maldonado G, Matthews R, Delzell E. An updated study of mortality among North American synthetic rubber industry workers. Occup Environ Med. 2005; 62:822-829. (Pubitemid 41729770)
9. Sathiakumar N, Delzell E, Cheng H, Lynch J, Sparks W, Macaluso M. Validation of 1,3-butadiene exposure estimates for workers at a synthetic rubber plant. Chem Biol Interact. 2007;166: 29-43. (Pubitemid 46420699)
10. Sathiakumar N, Delzell E, Hovinga M, et al. Mortality from cancer and other causes of death among synthetic rubber workers. Occup Environ Med. 1998;55: 230-235.
11. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. In: 1,3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide). Vol.97. Lyon, France: IARC Press; 2008:45-184.
12. IARC. IARC monographs on the evaluation of carcinogenic risks to humans. In: Some Traditional Herbal Medicines, Some Mycotoxins, Naphthalene and Styrene. Vol.82. Lyon, France: IARC Press; 2002:437-550.
13. Anderson D, Dobrzynka MM, Jackson LI, Yu TW, Brinkworth MH. Somatic and germ cell effects in rats and mice after treatment with 1,3-butadiene and its metabolites, 1,2-epoxybutene and 1,2,3,4-diepoxybutane. Mutat Res. 1997; 391:233-242.
14. Anderson D, Hughes JA, Edwards AJ, Brinkworth MH. A comparison of malemediated effects in rats and mice exposed to 1,3-butadiene. Mutat Res. 1998;397: 77-84.
15. Anderson D, Brinkworth MH. Malemediated F1 effects in mice exposed to BD. BD and styrene: assessment of health hazards. In: Sorsa KPH, Vainio H, Hemminki K, eds. IARC Scientific Publications No 127. Lyon, France: Lyon International Agency for Research on Cancer; 1993:171-181.
16. Himmelstein MW, Acquavella JF, Recio L, Medinsky MA, Bond JA. Toxicology and epidemiology of 1,3-butadiene. Crit Rev Toxicol. 1997;27:1-108.
17. Huff JE, Melnick RL, Solleveld HA, Haseman JK, Powers M, Miller RA. Multiple organ carcinogenicity of 1,3- butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science. 1985;227:548-549.
18. Irons RD, Cathro HP, Stillman WS, Steinhagen WH, Shah RS. Susceptibility to 1,3-butadiene-induced leukemogenesis correlates with endogenous ecotropic retroviral background in the mouse. Toxicol Appl Pharmacol. 1989;101:170-176.
19. Irons RD, Smith CN, Stillman WS, Shah RS, Steinhagen WH, Leiderman LJ. Macrocytic-megaloblastic anemia in male NIH Swiss mice following repeated exposure to 1,3-butadiene. Toxicol Appl Pharmacol. 1986;85:450-455.
20. Irons RD, Smith CN, Stillman WS, Shah RS, Steinhagen WH, Leiderman LJ. Macrocytic-megaloblastic anemia in male B6C3F1 mice following chronic exposure to 1,3-butadiene. Toxicol Appl Pharmacol. 1986;83:95-100.
21. Irons RD, Stillman WS, Cloyd MW. Selective activation of endogenous ecotropic retrovirus in hematopoietic tissues of B6C3F1 mice during the preleukemic phase of 1,3-butadiene exposure. Virology. 1987;161:457-462.
22. Melnick RL, Huff J, Chou BJ, Miller RA. Carcinogenicity of 1,3-butadiene in C57BL/6 x C3H F1 mice at low exposure concentrations. Cancer Res. 1990;50: 6592-6599.
23. Melnick RL, Huff JE, Haseman JK, Mc- Connell EE. Chronic toxicity results and ongoing studies of 1,3-butadiene by the National Toxicology Program. Ann N Y Acad Sci. 1988;534:648-662.
24. Owen PE, Glaister JR, Gaunt IF, Pullinger DH. Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/ carcinogenicity study in rats. Am Ind Hyg Assoc J. 1987;48:407-413.
25. U. S. Department of Health and Human Services. Report on Carcinogens, 8th ed. Washington, DC: U. S. Department of Health and Human Services; 1998:NO1- ES-25346.
26. Miller RA, Boorman GA. Morphology of neoplastic lesions induced by 1,3- butadiene in BgC3f1 mice. Environ Health Perspect. 1990;86:37-48.
27. Ponomarkov V, Tomatis L. Effects of long-term oral administration of styrene to mice and rats. Scan J Work Environ Health. 1978;4(suppl 2):127-135.
28. U.S. National Cancer Institute. Bioassay of Styrene for Possible Carcinogenicity. CAS No. 100-42-5. Tech. Rep. Ser. No. 185; DHEW Publ. No. NIH 79-1742. Washington, DC: U.S. Government Printing Office; 1979.
29. U.S. National Cancer Institute. Bioassay of a Solution of ß-Nitrostyrene and Styrene for Possible Carcinogenicity. CAS No. 102-96-5; CAS No. 100-42-5. Tech. Rep. Ser. No. 170; DHEW Publ. No. NIH 79-1726. Washington, DC: U.S. Government Printing Office; 1979.
30. Cruzan G, Cushman JR, Andrews LS, et al. Chronic toxicity/oncogenicity study of styrene in CD-1 mice by inhalation exposure for 104 weeks. J Appl Toxicol. 2001;21:185-198.
31. Conti B, Maltoni C, Perino G, Ciliberti A. Long-term carcinogenicity bioassays on styrene administration by inhalation, ingestion and injection and styrene oxide administered by ingestion in Sprague-Dawley rats, and para-methylstyrene administered by ingestion in Sprague-Dawley rats and Swiss mice. Ann N Y Acad Sci. 1988;534: 203-234. (Pubitemid 18205921)
32. Cruzan G, Cushman JR, Andrews LS, et al. Chronic toxicity/oncogenicity study of styrene in CD rats by inhalation exposure for 104 weeks. Toxicol Sci. 1998;46: 266-281.
33. Lijinsky W. Rat and mouse forestomach tumors induced by chronic oral administration of styrene oxide. J Natl Cancer Inst. 1986;77:471-476.
34. Sathiakumar N, Delzell E, Abdalla O. Using the National Death Index to obtain underlying cause of death codes. J Occup Environ Med. 1998;40:808-813.
35. Marsh GM, Youk AO, Stone RA, Sefcik S, Alcorn C. OCMAP-PLUS: a program for the comprehensive analysis of occupational cohort data. J Occup Environ Med. 1998;40:351-362.
36. Breslow NE, Day NE. Statistical Methods in Cancer Research: Volume ll: The Design and Analysis of Cohort Studies. IARC Scientific Publications No. 82. New York, NY: Oxford University Press; 1987.
37. Callas PW, Pastides H, Hosmer DW. Empirical comparisons of proportional hazards, Poisson, and logistic regression modeling of occupational cohort data. Am J Ind Med. 1998;33:33-47.
38. SAS Institute Inc. SAS7 technical report P-243. In: SAS/STAT7 Software: The GENMOD Procedure, Release 609. Cary, NC: SAS Institute, Inc; 1993.
39. Greenland S. Dose-response and trend analysis in epidemiology: alternatives to categorical analysis. Epidemiology. 1995; 6:356-365.
40. Axelson O, Steenland K. Indirect methods of assessing the effects of tobacco use in occupational studies. Am J Ind Med. 1988;13:105-118.
41. Brackbill R, Frazier T, Shilling S. Smoking characteristics of US workers, 1978-1980. Am J Ind Med. 1988;13:5-41.
42. National Center for Health Statistics. Smoking and Other Tobacco Use: United States, 1987. (Vital and Health Statistics, Series 10, No. 169). Hyattsville, MD: National Center for Health Statistics, 1989.
43. Thun MJ, Apicella LF, Henley SJ. Smoking vs other risk factors as the cause of smoking-attributable deaths: confounding in the courtroom. JAMA. 2000;284: 706-712.
44. Albertini RJ, Sram RJ, Vacek PM, et al. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons. Chem Biol Interact. 2007;166:63-77.
45. Alder N, Fenty J, Warren F, et al. Metaanalysis of mortality and cancer incidence among workers in the synthetic rubber-producing industry. Am J Epidemiol. 2006;164:405-420.
46. Kogevinas M, Ferro G, Saracci R, et al. Cancer mortality in an international cohort of workers exposed to styrene. In: Sorsa K, Peltonen HVH, Hemminki K, eds. Butadiene and Styrene: Assessment of Health Hazards. Lyon, France: WHO, IARC; 1993:289-300.
47. Kogevinas M, Ferro G, Andersen A, et al. Cancer mortality in a historical cohort study of workers exposed to styrene. Scand J Work Environ Health. 1994;20: 251-261.
48. Kolstad HA, Juel K, Olsen J, Lynge E. Exposure to styrene and chronic health effects: mortality and incidence of solid cancers in the Danish reinforced plastics industry. Occup Environ Med. 1995;52: 320-327.
49. Ruder AM, Ward EM, Dong M, Okun AH, Davis-King K. Mortality patterns among workers exposed to styrene in the reinforced plastic boatbuilding industry: an update. Am J Ind Med. 2004;45:165-176.
50. Wong O, Trent LS, Whorton MD. An updated cohort mortality study of workers exposed to styrene in the reinforced plastics and composites industry. Occup Environ Med. 1994;51:386-396.
51. Colditz GA, Baer HJ, Tamini RM. Breast cancer. In: Schottenfeld SD, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 2006:995-1012.
52. Neuberger JS, Mahnken JD, Mayo MS, Field RW. Risk factors for lung cancer in Iowa women: implications for prevention. Cancer Detect Prev. 2006;30:158-167.
53. Divine BJ, Hartman CM. A cohort mortality study among workers at a 1,3 butadiene facility. Chem Biol Interact. 2001; 135-136:535-553.
54. Tsai SP, Wendt JK, Randsell JD. A mortality, morbidity, and hematology study of petrochemical employees potentially exposed to 1,3-butadiene monomer. Chem Biol Interact 2001;135-136:555-567.
55. Boffetta P, Adami HO, Cole P, Trichopoulos D, Mandel JS. Epidemiologic studies of styrene and cancer: a review of the literature. J Occup Environ Med. In press.
56. Kolstad HA, Lynge E, Olsen J. Cancer incidence in the Danish reinforced plastics industry. IARC Sci Publ. 1993;127: 301-308.
57. Silverman DT, Devasa SS, Moore LE, Rothman N. Bladder cancer. In: Schontenfeld SD, Fraumeni JF, eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 2006:110001127.